Marino Garcia is Director, President and Chief Executive Officer of Dianthus Therapeutics, Inc. (DNTH). The company reported total compensation of $10,614,702 for fiscal year 2025.
| Salary | $630,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $9,450,952 |
| Non-equity incentive plan | $519,750 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $10,614,702 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Dianthus Therapeutics, Inc. filed April 9, 2026, accession 0001690585-26-000012.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Director, President and Chief Executive Officer | $630,000 | $0 | $0 | $9,450,952 | $519,750 | $0 | $14,000 | $10,614,702 |
| FY2024 | Director, President and Chief Executive Officer | $600,000 | $0 | $0 | $7,899,500 | $330,000 | $0 | $13,800 | $8,843,300 |
Totals as disclosed in each year's own compensation disclosure for Dianthus Therapeutics, Inc..
| Peer-group chief executive median | $5,045,055 |
|---|---|
| Difference from that median | $5,569,647 |
| Percentile within the disclosed peer group | 94th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Dianthus Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Marino Garcia this page | Director, President and Chief Executive Officer | $10,614,702 |
| Simrat Randhawa | Executive Vice President, Head of Research and Development | $5,221,537 |
| Ryan Savitz | Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $5,074,953 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Dianthus Therapeutics, Inc. compensation brief.
Marino Garcia's compensation sits inside Dianthus Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.